Clinical trials
Phase 3 Inflammatory Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 4 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 4 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GBG Forschungs GmbH | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Scottish Cancer Therapy Network | 2 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Hoffmann-La Roche | 1 |
| Joseph Roscoe | 1 |
| National Cancer Institute (NCI) | 1 |
| RenJi Hospital | 1 |
| SWOG Cancer Research Network | 1 |
| UNICANCER | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Breast Neoplasms | 14 |
| Breast Neoplasms | 10 |
| Carcinoma, Ductal, Breast | 3 |
| Breast Neoplasms, Male | 2 |
| Cardiotoxicity | 2 |
| Nausea | 1 |
| Postoperative Complications | 1 |
| Vomiting | 1 |
Trials
Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.